Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 35 entries
Sorted by: Best Match Show Resources per page
Tapentadol: Can It Kill Two Birds with One Stone without Breaking Windows?.

The Korean journal of pain

Chang EJ, Choi EJ, Kim KH.
PMID: 27413479
Korean J Pain. 2016 Jul;29(3):153-7. doi: 10.3344/kjp.2016.29.3.153. Epub 2016 Jul 01.

Tapentadol is a novel oral analgesic with a dual mode of action as an agonist of the µ-opioid receptor (MOR), and as a norepinephrine reuptake inhibitor (NRI) all in a single molecule. Immediate release (IR) tapentadol shows its analgesic...

Cite
Chang EJ, Choi EJ, Kim KH. Tapentadol: Can It Kill Two Birds with One Stone without Breaking Windows?. Korean J Pain. 2016;29(3):153-7doi: 10.3344/kjp.2016.29.3.153.
Chang, E. J., Choi, E. J., & Kim, K. H. (2016). Tapentadol: Can It Kill Two Birds with One Stone without Breaking Windows?. The Korean journal of pain, 29(3), 153-7. https://doi.org/10.3344/kjp.2016.29.3.153
Chang, Eun Jung, et al. "Tapentadol: Can It Kill Two Birds with One Stone without Breaking Windows?." The Korean journal of pain vol. 29,3 (2016): 153-7. doi: https://doi.org/10.3344/kjp.2016.29.3.153
Chang EJ, Choi EJ, Kim KH. Tapentadol: Can It Kill Two Birds with One Stone without Breaking Windows?. Korean J Pain. 2016 Jul;29(3):153-7. doi: 10.3344/kjp.2016.29.3.153. Epub 2016 Jul 01. PMID: 27413479; PMCID: PMC4942642.
Copy Download .nbib Format: NLM
Chloral Hydrate Overdose Survived after Cardiac Arrest with Excellent Response to Intravenous β-blocker.

Oman medical journal

Shakeer SK, Kalapati B, Al Abri SA, Al Busaidi M.
PMID: 31110633
Oman Med J. 2019 May;34(3):244-248. doi: 10.5001/omj.2019.46.

Chloral hydrate (CH) poisoning is not commonly seen in the emergency department. CH is a commonly prescribed sedative agent for various day care procedures despite its toxic profile even when other safe sedative medications are available. We report a...

Cite
Shakeer SK, Kalapati B, Al Abri SA, et al. Chloral Hydrate Overdose Survived after Cardiac Arrest with Excellent Response to Intravenous β-blocker. Oman Med J. 2019;34(3):244-248doi: 10.5001/omj.2019.46.
Shakeer, S. K., Kalapati, B., Al Abri, S. A., & Al Busaidi, M. (2019). Chloral Hydrate Overdose Survived after Cardiac Arrest with Excellent Response to Intravenous β-blocker. Oman medical journal, 34(3), 244-248. https://doi.org/10.5001/omj.2019.46
Shakeer, Shaik Karimulla, et al. "Chloral Hydrate Overdose Survived after Cardiac Arrest with Excellent Response to Intravenous β-blocker." Oman medical journal vol. 34,3 (2019): 244-248. doi: https://doi.org/10.5001/omj.2019.46
Shakeer SK, Kalapati B, Al Abri SA, Al Busaidi M. Chloral Hydrate Overdose Survived after Cardiac Arrest with Excellent Response to Intravenous β-blocker. Oman Med J. 2019 May;34(3):244-248. doi: 10.5001/omj.2019.46. PMID: 31110633; PMCID: PMC6505342.
Copy Download .nbib Format: NLM
Association of Therapies With Reduced Pain and Improved Quality of Life in Patients With Fibromyalgia: A Systematic Review and Meta-analysis.

JAMA internal medicine

Mascarenhas RO, Souza MB, Oliveira MX, Lacerda AC, Mendonça VA, Henschke N, Oliveira VC.
PMID: 33104162
JAMA Intern Med. 2021 Jan 01;181(1):104-112. doi: 10.1001/jamainternmed.2020.5651.

IMPORTANCE: Fibromyalgia is a chronic condition that results in a significant burden to individuals and society.OBJECTIVE: To investigate the effectiveness of therapies for reducing pain and improving quality of life (QOL) in people with fibromyalgia.DATA SOURCES: Searches were performed...

Cite
Mascarenhas RO, Souza MB, Oliveira MX, et al. Association of Therapies With Reduced Pain and Improved Quality of Life in Patients With Fibromyalgia: A Systematic Review and Meta-analysis. JAMA Intern Med. 2021;181(1):104-112doi: 10.1001/jamainternmed.2020.5651.
Mascarenhas, R. O., Souza, M. B., Oliveira, M. X., Lacerda, A. C., Mendonça, V. A., Henschke, N., & Oliveira, V. C. (2021). Association of Therapies With Reduced Pain and Improved Quality of Life in Patients With Fibromyalgia: A Systematic Review and Meta-analysis. JAMA internal medicine, 181(1), 104-112. https://doi.org/10.1001/jamainternmed.2020.5651
Mascarenhas, Rodrigo Oliveira, et al. "Association of Therapies With Reduced Pain and Improved Quality of Life in Patients With Fibromyalgia: A Systematic Review and Meta-analysis." JAMA internal medicine vol. 181,1 (2021): 104-112. doi: https://doi.org/10.1001/jamainternmed.2020.5651
Mascarenhas RO, Souza MB, Oliveira MX, Lacerda AC, Mendonça VA, Henschke N, Oliveira VC. Association of Therapies With Reduced Pain and Improved Quality of Life in Patients With Fibromyalgia: A Systematic Review and Meta-analysis. JAMA Intern Med. 2021 Jan 01;181(1):104-112. doi: 10.1001/jamainternmed.2020.5651. PMID: 33104162; PMCID: PMC7589080.
Copy Download .nbib Format: NLM
Risk of respiratory depression with opioids and concomitant gabapentinoids.

Journal of pain research

Savelloni J, Gunter H, Lee KC, Hsu C, Yi C, Edmonds KP, Furnish T, Atayee RS.
PMID: 29180889
J Pain Res. 2017 Nov 10;10:2635-2641. doi: 10.2147/JPR.S144963. eCollection 2017.

INTRODUCTION: The combination of opioids and central nervous system depressants such as benzodiazepines and barbiturates has an additive effect on the frequency of oversedation and respiratory depression requiring naloxone use in hospitalized patients. Gabapentinoids (gabapentin and pregabalin) are frequently...

Cite
Savelloni J, Gunter H, Lee KC, et al. Risk of respiratory depression with opioids and concomitant gabapentinoids. J Pain Res. 2017;10:2635-2641doi: 10.2147/JPR.S144963.
Savelloni, J., Gunter, H., Lee, K. C., Hsu, C., Yi, C., Edmonds, K. P., Furnish, T., & Atayee, R. S. (2017). Risk of respiratory depression with opioids and concomitant gabapentinoids. Journal of pain research, 102635-2641. https://doi.org/10.2147/JPR.S144963
Savelloni, Julie, et al. "Risk of respiratory depression with opioids and concomitant gabapentinoids." Journal of pain research vol. 10 (2017): 2635-2641. doi: https://doi.org/10.2147/JPR.S144963
Savelloni J, Gunter H, Lee KC, Hsu C, Yi C, Edmonds KP, Furnish T, Atayee RS. Risk of respiratory depression with opioids and concomitant gabapentinoids. J Pain Res. 2017 Nov 10;10:2635-2641. doi: 10.2147/JPR.S144963. eCollection 2017. PMID: 29180889; PMCID: PMC5691933.
Copy Download .nbib Format: NLM
Development and Application of a Measurement Framework to Evaluate Safe, Effective and Efficient Medication Use Among Older Adults.

Drugs - real world outcomes

Vyas A, Patry E, Owens N, Belviso N, Kogut SJ.
PMID: 31456064
Drugs Real World Outcomes. 2019 Dec;6(4):173-181. doi: 10.1007/s40801-019-00162-x.

BACKGROUND: A majority of older adults in the United States (US) use prescription medications. Comprehensive population-level approaches to examine medication safety, effectiveness, and costs among older adults are needed.OBJECTIVES: The objectives of this study were to develop a framework...

Cite
Vyas A, Patry E, Owens N, et al. Development and Application of a Measurement Framework to Evaluate Safe, Effective and Efficient Medication Use Among Older Adults. Drugs Real World Outcomes. 2019;6(4):173-181doi: 10.1007/s40801-019-00162-x.
Vyas, A., Patry, E., Owens, N., Belviso, N., & Kogut, S. J. (2019). Development and Application of a Measurement Framework to Evaluate Safe, Effective and Efficient Medication Use Among Older Adults. Drugs - real world outcomes, 6(4), 173-181. https://doi.org/10.1007/s40801-019-00162-x
Vyas, Ami, et al. "Development and Application of a Measurement Framework to Evaluate Safe, Effective and Efficient Medication Use Among Older Adults." Drugs - real world outcomes vol. 6,4 (2019): 173-181. doi: https://doi.org/10.1007/s40801-019-00162-x
Vyas A, Patry E, Owens N, Belviso N, Kogut SJ. Development and Application of a Measurement Framework to Evaluate Safe, Effective and Efficient Medication Use Among Older Adults. Drugs Real World Outcomes. 2019 Dec;6(4):173-181. doi: 10.1007/s40801-019-00162-x. PMID: 31456064; PMCID: PMC6879678.
Copy Download .nbib Format: NLM
Substance-Induced Psychosis.

Seminars in clinical neuropsychiatry

Bacon A, Granholm E, Withers N.
PMID: 10085193
Semin Clin Neuropsychiatry. 1998 Jan;3(1):70-79.

Intoxication and withdrawal from a variety of central nervous system depressants and stimulants may induce hallucinations or delusions, which, when unaccompanied by insight, are the hallmarks of psychosis. A substance-induced psychosis may, in many instances, present as an organic...

Cite
Bacon A, Granholm E, Withers N. Substance-Induced Psychosis. Semin Clin Neuropsychiatry. 1998;3(1):70-79
Bacon, A., Granholm, E., & Withers, N. (1998). Substance-Induced Psychosis. Seminars in clinical neuropsychiatry, 3(1), 70-79.
Bacon, et al. "Substance-Induced Psychosis." Seminars in clinical neuropsychiatry vol. 3,1 (1998): 70-79.
Bacon A, Granholm E, Withers N. Substance-Induced Psychosis. Semin Clin Neuropsychiatry. 1998 Jan;3(1):70-79. PMID: 10085193.
Copy Download .nbib Format: NLM
Missed Opportunities for Sedation and Pain Management at a Level III Neonatal Intensive Care Unit, India.

Frontiers in pediatrics

Kothari SY, Dongara AR, Nimbalkar SM, Phatak AG, Nimbalkar AS.
PMID: 26942166
Front Pediatr. 2016 Feb 23;4:7. doi: 10.3389/fped.2016.00007. eCollection 2016.

BACKGROUND: Neonates in the neonatal intensive care unit (NICU) undergo a multitude of painful and stressful procedures during the first days of life. Stress from this pain can lead to neurodevelopmental problems that manifest in later childhood and should...

Cite
Kothari SY, Dongara AR, Nimbalkar SM, et al. Missed Opportunities for Sedation and Pain Management at a Level III Neonatal Intensive Care Unit, India. Front Pediatr. 2016;4:7doi: 10.3389/fped.2016.00007.
Kothari, S. Y., Dongara, A. R., Nimbalkar, S. M., Phatak, A. G., & Nimbalkar, A. S. (2016). Missed Opportunities for Sedation and Pain Management at a Level III Neonatal Intensive Care Unit, India. Frontiers in pediatrics, 47. https://doi.org/10.3389/fped.2016.00007
Kothari, Shikha Y, et al. "Missed Opportunities for Sedation and Pain Management at a Level III Neonatal Intensive Care Unit, India." Frontiers in pediatrics vol. 4 (2016): 7. doi: https://doi.org/10.3389/fped.2016.00007
Kothari SY, Dongara AR, Nimbalkar SM, Phatak AG, Nimbalkar AS. Missed Opportunities for Sedation and Pain Management at a Level III Neonatal Intensive Care Unit, India. Front Pediatr. 2016 Feb 23;4:7. doi: 10.3389/fped.2016.00007. eCollection 2016. PMID: 26942166; PMCID: PMC4763094.
Copy Download .nbib Format: NLM
Opioid analgesics increase incidence of somnolence and dizziness as adverse effects of pregabalin: a retrospective study.

Journal of pharmaceutical health care and sciences

Ohishi A, Chisaki Y, Hira D, Nagasawa K, Terada T.
PMID: 26819741
J Pharm Health Care Sci. 2015 Dec 01;1:30. doi: 10.1186/s40780-015-0032-5. eCollection 2015.

BACKGROUND: Pregabalin, a gabapentinoid, is an adjuvant analgesic for treatment of neuropathic pain, but it has serious adverse effects such as somnolence and dizziness, particularly in elderly patients. Although decreased renal function is considered to the contributing factor for...

Cite
Ohishi A, Chisaki Y, Hira D, et al. Opioid analgesics increase incidence of somnolence and dizziness as adverse effects of pregabalin: a retrospective study. J Pharm Health Care Sci. 2015;1:30doi: 10.1186/s40780-015-0032-5.
Ohishi, A., Chisaki, Y., Hira, D., Nagasawa, K., & Terada, T. (2015). Opioid analgesics increase incidence of somnolence and dizziness as adverse effects of pregabalin: a retrospective study. Journal of pharmaceutical health care and sciences, 130. https://doi.org/10.1186/s40780-015-0032-5
Ohishi, Akihiro, et al. "Opioid analgesics increase incidence of somnolence and dizziness as adverse effects of pregabalin: a retrospective study." Journal of pharmaceutical health care and sciences vol. 1 (2015): 30. doi: https://doi.org/10.1186/s40780-015-0032-5
Ohishi A, Chisaki Y, Hira D, Nagasawa K, Terada T. Opioid analgesics increase incidence of somnolence and dizziness as adverse effects of pregabalin: a retrospective study. J Pharm Health Care Sci. 2015 Dec 01;1:30. doi: 10.1186/s40780-015-0032-5. eCollection 2015. PMID: 26819741; PMCID: PMC4729150.
Copy Download .nbib Format: NLM
Challenges of Drug-Facilitated Sexual Assault.

Forensic science review

LeBeau MA, Montgomery MA.
PMID: 26242451
Forensic Sci Rev. 2010 Jan;22(1):1-6.

This article provides the reader with an understanding of the numerous challenges of drug-facilitated sexual assaults (DFSA). The challenges are categorized as follows: the drugs, reporting the crime, evidence collection, and laboratory analysis of specimens. The challenges associated with...

Cite
LeBeau MA, Montgomery MA. Challenges of Drug-Facilitated Sexual Assault. Forensic Sci Rev. 2010;22(1):1-6
LeBeau, M. A., & Montgomery, M. A. (2010). Challenges of Drug-Facilitated Sexual Assault. Forensic science review, 22(1), 1-6.
LeBeau, M A, and Montgomery, M A. "Challenges of Drug-Facilitated Sexual Assault." Forensic science review vol. 22,1 (2010): 1-6.
LeBeau MA, Montgomery MA. Challenges of Drug-Facilitated Sexual Assault. Forensic Sci Rev. 2010 Jan;22(1):1-6. PMID: 26242451.
Copy Download .nbib Format: NLM
History of Respiratory Stimulants.

Journal of pain research

Peppin JF, Pergolizzi JV, Fudin J, Meyer TA, Raffa RB.
PMID: 33889020
J Pain Res. 2021 Apr 16;14:1043-1049. doi: 10.2147/JPR.S298607. eCollection 2021.

The interest in substances that stimulate respiration has waxed and waned throughout the years, intensifying following the introduction of a new class of drugs that causes respiratory depression, and diminishing when antidotes or better drug alternatives are found. Examples...

Cite
Peppin JF, Pergolizzi JV, Fudin J, et al. History of Respiratory Stimulants. J Pain Res. 2021;14:1043-1049doi: 10.2147/JPR.S298607.
Peppin, J. F., Pergolizzi, J. V., Fudin, J., Meyer, T. A., & Raffa, R. B. (2021). History of Respiratory Stimulants. Journal of pain research, 141043-1049. https://doi.org/10.2147/JPR.S298607
Peppin, John F, et al. "History of Respiratory Stimulants." Journal of pain research vol. 14 (2021): 1043-1049. doi: https://doi.org/10.2147/JPR.S298607
Peppin JF, Pergolizzi JV, Fudin J, Meyer TA, Raffa RB. History of Respiratory Stimulants. J Pain Res. 2021 Apr 16;14:1043-1049. doi: 10.2147/JPR.S298607. eCollection 2021. PMID: 33889020; PMCID: PMC8057823.
Copy Download .nbib Format: NLM
Driving under the Influence of Flualprazolam: 11 Case Reports.

Journal of analytical toxicology

Mercurio N, Triebold C, Coleman D.
PMID: 34529082
J Anal Toxicol. 2021 Sep 16; doi: 10.1093/jat/bkab105. Epub 2021 Sep 16.

Eleven cases of suspected driving under the influence (DUI) of flualprazolam are presented. Data from police reports and drug recognition examinations (DRE), when available, were evaluated. In all cases, significant driving impairments were observed including weaving, driving slowly, stopping...

Cite
Mercurio N, Triebold C, Coleman D. Driving under the Influence of Flualprazolam: 11 Case Reports. J Anal Toxicol. 2021;doi: 10.1093/jat/bkab105.
Mercurio, N., Triebold, C., & Coleman, D. (2021). Driving under the Influence of Flualprazolam: 11 Case Reports. Journal of analytical toxicology, . https://doi.org/10.1093/jat/bkab105
Mercurio, Nicholas, et al. "Driving under the Influence of Flualprazolam: 11 Case Reports." Journal of analytical toxicology vol. (2021). doi: https://doi.org/10.1093/jat/bkab105
Mercurio N, Triebold C, Coleman D. Driving under the Influence of Flualprazolam: 11 Case Reports. J Anal Toxicol. 2021 Sep 16; doi: 10.1093/jat/bkab105. Epub 2021 Sep 16. PMID: 34529082.
Copy Download .nbib Format: NLM
Opioid toxicity due to CNS depressant polypharmacy: A case report.

The mental health clinician

Lee C, Wanson A, Frangou S, Chong D, Halpape K.
PMID: 33850686
Ment Health Clin. 2021 Mar 31;11(2):70-74. doi: 10.9740/mhc.2021.03.070. eCollection 2021 Mar.

The interaction between methadone and central nervous system depressants can cause serious adverse effects, including profound sedation, respiratory depression, coma, and death. This poses a challenge in the treatment of patients with concurrent psychiatric and substance use disorders as...

Cite
Lee C, Wanson A, Frangou S, et al. Opioid toxicity due to CNS depressant polypharmacy: A case report. Ment Health Clin. 2021;11(2):70-74doi: 10.9740/mhc.2021.03.070.
Lee, C., Wanson, A., Frangou, S., Chong, D., & Halpape, K. (2021). Opioid toxicity due to CNS depressant polypharmacy: A case report. The mental health clinician, 11(2), 70-74. https://doi.org/10.9740/mhc.2021.03.070
Lee, Christine, et al. "Opioid toxicity due to CNS depressant polypharmacy: A case report." The mental health clinician vol. 11,2 (2021): 70-74. doi: https://doi.org/10.9740/mhc.2021.03.070
Lee C, Wanson A, Frangou S, Chong D, Halpape K. Opioid toxicity due to CNS depressant polypharmacy: A case report. Ment Health Clin. 2021 Mar 31;11(2):70-74. doi: 10.9740/mhc.2021.03.070. eCollection 2021 Mar. PMID: 33850686; PMCID: PMC8019539.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 35 entries